Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Role of Regional/Ethnic Differences: Focus on Asia
- PMID: 38371293
- PMCID: PMC10866728
- DOI: 10.1016/j.jacasi.2023.11.010
Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Role of Regional/Ethnic Differences: Focus on Asia
Keywords: Asia, dapagliflozin, ethnicity; heart failure; heart failure with mildly reduced ejection fraction; heart failure with preserved ejection fraction, regional differences; sodium-glucose cotransporter-2 inhibitor.
Conflict of interest statement
Dr Crisci has received a research grant from the CardioPath program, Federico II University, Naples, Italy. Dr Salzano has reported that he has no relationships relevant to the contents of this paper to disclose.
Figures
Comment on
- doi: 10.1016/j.jacasi.2023.10.005
References
-
- Savarese G., Becher P.M., Lund L.H., Seferovic P., Rosano G.M.C., Coats A.J.S. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272–3287. - PubMed
-
- Tsao C.W., Aday A.W., Almarzooq Z.I., et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93–e621. - PubMed
-
- Dokainish H., Teo K., Zhu J., et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5:e665–e672. - PubMed
-
- Martinez-Amezcua P., Haque W., Khera R., et al. The upcoming epidemic of heart failure in South Asia. Circ Heart Fail. 2020;13 - PubMed
-
- Hao G., Wang X., Chen Z., et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail. 2019;21:1329–1337. - PubMed
Publication types
LinkOut - more resources
Full Text Sources